期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重组腺病毒载体靶向性策略的研究进展 被引量：3

下载PDF
导出
摘要 近年来，研究者致力于突破基因治疗的瓶颈，极大推动了基因治疗的发展。载体系统是基因治疗的基础，截止2013年7月，在“Gene Therapy Clinical Trial Worldwide”网站登记注册的基因治疗方案中，重组腺病毒载体占476项（23.5%）。在6个亚群（A-F）、50多种血清型的腺病毒载体中，5型腺病毒（adenovirus type 5，Ad5）可特异性识别并结合多种正常组织高表达的柯萨奇病毒-腺病毒受体（coxsackie-adenovirus receptor，CAR）从而进入细胞发挥作用，基因转导效率高，因此，Ad5是目前应用最广泛的腺病毒载体。
作者 薛淑雅 杨月峰
机构地区 安徽医科大学研究生院 军事医学科学院放射与辐射医学研究所实验血液学研究室
出处 《中国医药生物技术》 2014年第2期129-132,共4页 Chinese Medicinal Biotechnology
基金 国家高技术发展研究计划(863计划)(2012AA020807) 国家自然科学基金(30901379)
关键词 重组腺病毒载体 靶向性策略 柯萨奇病毒-腺病毒受体 RECEPTOR 基因治疗 基因转导效率 特异性识别 载体系统
分类号 R346 [医药卫生—基础医学]
  • 相关文献

参考文献38

  • 1Bergelson JM, Cunningham JA, Droguett G. Isolation of a Science, common receptor for Coxsackie B viruses and adenoviruses 2 and 5. 1997, 275(5304): 1320-1323.
  • 2王振发,王烈,卫立辛.基因治疗病毒载体的研究进展[J].医学综述,2007,13(7):490-492. 被引量：11
  • 3Wickham TJ, Tzeng E, Shears LL 2rid, et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol, 1997, 71(11):8221-8229.
  • 4Murugesan SR, Akiyama M, Einfeld DA, et al. Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor. Int J Oncol, 2007, 31(4):813-822.
  • 5Wang M, Hemminki A, Siegal GP, et al. Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery. Gynecol Oncol, 2005, 96(2):341-348.
  • 6Lu ZZ, Ni F, Hu ZB, et al. Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11 p. Exp Hematol, 2006, 34(9):1171-1182.
  • 7Bauverschmitz GJ, Guse K, Kanerva A, et al. Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transc omple ment ation, and serotype chimerism for enhanced selectivity for ovarian cancer cells. Mol Ther, 2006, 14(2): 164-174.
  • 8Witlox AM, Van Beusechem VW, Molenaar B, et al. Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivo. Clin Cancer Res, 2004, 10(1 Pt 1):61-67.
  • 9Printz MA, Gonzalez AM, Cunningham M, et al. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors. Hum Gene Ther, 2000, 11 (1): 191-204.
  • 10Rancourt C, Rogers BE, Sosnowski BA, et al. Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer. Clin Cancer Res, 1998, 4(10):2455-2461.

二级参考文献75

  • 1李振宇,徐开林,潘秀英,鹿群先,何徐彭,孙海英,主鸿鹄.HIV-1慢病毒载体的构建及结构改造[J].中华血液学杂志,2004,25(9):571-572. 被引量：21
  • 2Zhang ZL et al. Cell Res, 2003, 13(6): 481-489.
  • 3Russell WC. J Gen Virol, 2000, 81(pt11): 2573-2604.
  • 4Yotnda P et al. Blood, 2004, 104(8): 2272-2280.
  • 5Kamizono J et al. Cancer Res, 2005, 65(12): 5284-5291.
  • 6Li X et al. Cancer Res, 2005.65(5): 1941-1951.
  • 7Sarkar D et al. Proc Natl Acad Sci USA, 2005, 102: 14034-14039.
  • 8Zou WG et al. Oncogene, 2004, 23(2): 457-464.
  • 9Li Y et al. Mol Cancer Ther, 2003, 2(10): 1003-1009.
  • 10Zhang L et al. Mol Ther, 2002, 6(3): 386-393.

共引文献34

同被引文献28

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA CancerJ Clin, 2013, 63(1):11-30.
  • 2Jemal A, Bray F, Cente MM, et al. Global Cancer Statistics[J].CA CancerJ Clin, 2011, 61(2):69-90.
  • 3Coticchia CM, YangJ, Moses MA. Ovarian cancer biomarkers: cur- rent options and future promise[J].J Natl Cornpr Canc Netw, 2008, 6 (8) :795-802.
  • 4Kondalsamy-Chelmakesavan S, Hackethal A, Bowtell D, et al. Dif- ferentiating Stage 1 epithefial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age[J]. Gynecol Oncol, 2013, 129(3):467-471.
  • 5Kerstin B, Brining H, Galy A, et al. Gene therapy on the move[J]. EMBO Mol Med, 2013, 5(11):1642-1661.
  • 6Ireton GC, McDermott G, Black ME, et al. The structure of Esche- richia cob cytoshle deaminase[J].J Mol Biol, 2002, 315(4):687-697.
  • 7O'Reilly MS, Boehrn T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997, 88(2): 277-285.
  • 8Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease[J]. Science, 2000, 288(5466):669-672.
  • 9Samantha LG, Ian EA, Michael L, et al. Gene therapy clinical trials worldwide to 2012-an update[J].J Gene Med, 2013, 15(2):65-77.
  • 10Yi Bo-Rhn, Choi KJ, Kim SU, et al. Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: Evidence that they exert tumoricidal effects via tumor tropism[J]. InternationalJ Oncol, 2012, 41 (3):798-804.

引证文献3

二级引证文献6

中国医药生物技术
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部